cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/ccdc.csd.cc216k1w
title: CCDC 1883127: Experimental Crystal Structure Determination

description: Related Article: A. A. Titov,  O. A. Filippov,  A. F. Smol’yakov,  I. A. Godovikov,  J. R. Shakirova,  S. P. Tunik,  I. S. Podkorytov,  E. S. Shubina|2019|Inorg.Chem.|58|8645|doi:10.1021/acs.inorgchem.9b00991
DOI: 10.5517/ccdc.csd.cc20dx9n
title: CCDC 1859451: Experimental Crystal Structure Determination

description: Related Article: John Krautwurst,  Daniel Smets,  Rainer Lamann,  Uwe Ruschewitz|2019|Inorg.Chem.|58|8622|doi:10.1021/acs.inorgchem.9b00940
DOI: 10.25934/pr00005674.1
title: Available IPD datapackage for study 'A Randomized, Double-blind Study of the Effect of Tocilizumab on Reduction in Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis and Inadequate Response to DMARD Therapy'

description: This 2 arm study will compare the safety and efficacy, with regard to reduction of signs and symptoms, of tocilizumab versus placebo in combination with traditional Disease-Modifying Anti-Rheumatic Drug (DMARD) therapy in patients with moderate to severe active rheumatoid arthritis (RA) who have had an inadequate response to current DMARD therapy. Patients will be randomized to receive tocilizumab 8mg/kg iv or placebo iv every 4 weeks, in conjunction with stable DMARD therapy. The anticipated time on study treatment is 3-12 months, and the target sample size is 500+ individuals.
DOI: 10.5517/ccdc.csd.cc21xxb7
title: CCDC 1904619: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc21812g
title: CCDC 1884554: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc21813h
title: CCDC 1884555: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc21814j
title: CCDC 1884556: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc21815k
title: CCDC 1884557: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc21816l
title: CCDC 1884558: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc21817m
title: CCDC 1884559: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc21818n
title: CCDC 1884560: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc21819p
title: CCDC 1884561: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc2181bq
title: CCDC 1884562: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc2181cr
title: CCDC 1884563: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc2181ds
title: CCDC 1884564: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc2181ft
title: CCDC 1884565: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc2181gv
title: CCDC 1884566: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5517/ccdc.csd.cc2181hw
title: CCDC 1884567: Experimental Crystal Structure Determination

description: Related Article: Victor Ovcharenko,  Galina Romanenko,  Alexey Polushkin,  Gleb Letyagin,  Artem Bogomyakov,  Matvey Fedin,  Kseniya Maryunina,  Sadafumi Nishihara,  Katsuya Inoue,  Marina Petrova,  Vitaly Morozov,  Ekaterina Zueva|2019|Inorg.Chem.|58|9187|doi:10.1021/acs.inorgchem.9b00815
DOI: 10.5281/zenodo.5937376
title: Large-scale temporal graph datasets

description: Large scale datasets used for evaluation in the article: `Optimizing the Interval-centric Distributed<br> Computing Model for Temporal Graph Algorithms` to appear in `EuroSys 2022`.
DOI: 10.5281/zenodo.5937375
title: Large-scale temporal graph datasets

description: Large scale datasets used for evaluation in the article: `Optimizing the Interval-centric Distributed<br> Computing Model for Temporal Graph Algorithms` to appear in `EuroSys 2022`.
DOI: 10.48370/ofd/oevdtl/kvujnz
title: Erysiphe gorlenkoi (F. T. Chien) U. Braun & S. Takam. F-0694.tif

description: :unav
DOI: 10.48370/ofd/oevdtl
title: Erysiphe gorlenkoi (F. T. Chien) U. Braun S. Takam., 694

description: Fungarium Mikromycetes
DOI: 10.25934/pr00005673.2
title: Available IPD datapackage for study 'A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Rheumatoid Arthritis'

description: This 3 arm study will compare the safety and efficacy, with regard to reduction of signs and symptoms, of tocilizumab versus placebo, both in combination with methotrexate (MTX). in patients with moderate to severe active rheumatoid arthritis (RA) who currently have an inadequate response to MTX. Patients wil be randomized to receive tocilizumab 4mg/kg iv, tocilizumab 8mg/mg iv, or placebo iv, every 4 weeks; all patients will also receive methotrexate 10-25mg weekly. The anticipated time on study treatment is 3-12 months, and the target sample size is 500+ individuals.
DOI: 10.48370/ofd/aqpfhk/lycanx
title: Erysiphe hedwigii (Lév.) U. Braun & S. Takam. F-2677.tif

description: :unav
DOI: 10.48370/ofd/aqpfhk
title: Erysiphe hedwigii (Lév.) U. Braun S. Takam., 2677

description: Fungarium Mikromycetes
DOI: 10.48370/ofd/m3pw4y/ewxzyw
title: Erysiphe hedwigii (Lév.) U. Braun & S. Takam. F-2648.tif

description: :unav
DOI: 10.48370/ofd/m3pw4y
title: Erysiphe hedwigii (Lév.) U. Braun S. Takam., 2648

description: Fungarium Mikromycetes
DOI: 10.48370/ofd/7qhqdw/xjaeol
title: Erysiphe hedwigii (Lév.) U. Braun & S. Takam. F-0549.tif

description: :unav
DOI: 10.48370/ofd/7qhqdw
title: Erysiphe hedwigii (Lév.) U. Braun S. Takam., 549

description: Fungarium Mikromycetes
DOI: 10.5281/zenodo.5941385
title: Neural relational inference to learn long-range allosteric interactions in proteins from molecular dynamics simulations

description: MD simulations used in the studies of the publication "<strong>Neural relational inference to learn long-range allosteric interactions in proteins from molecular dynamics simulations</strong>"
description: {"references": ["Zhu, Jingxuan, Juexin Wang, Weiwei Han, and Dong Xu. \"Neural relational inference to learn allosteric long-range interactions in proteins from molecular dynamics simulations.\" bioRxiv (2021)."]}
DOI: 10.5281/zenodo.5941384
title: Neural relational inference to learn long-range allosteric interactions in proteins from molecular dynamics simulations

description: MD simulations used in the studies of the publication "<strong>Neural relational inference to learn long-range allosteric interactions in proteins from molecular dynamics simulations</strong>"
description: {"references": ["Zhu, Jingxuan, Juexin Wang, Weiwei Han, and Dong Xu. \"Neural relational inference to learn allosteric long-range interactions in proteins from molecular dynamics simulations.\" bioRxiv (2021)."]}
DOI: 10.48370/ofd/gyivyh/7serch
title: Erysiphe heraclei de Candolle F-0703.tif

description: :unav
DOI: 10.48370/ofd/gyivyh
title: Erysiphe heraclei de Candolle, 703

description: Fungarium Mikromycetes
DOI: 10.48370/ofd/i3n5jv/uyxztg
title: Erysiphe heraclei de Candolle F-0904.tif

description: :unav
DOI: 10.48370/ofd/i3n5jv
title: Erysiphe heraclei de Candolle, 904

description: Fungarium Mikromycetes
DOI: 10.48370/ofd/o5u3iw/6aekll
title: Erysiphe heraclei de Candolle F-2667.tif

description: :unav
DOI: 10.48370/ofd/o5u3iw
title: Erysiphe heraclei de Candolle, 2667

description: Fungarium Mikromycetes
DOI: 10.25934/pr00005672.2
title: Available IPD datapackage for study 'A Randomized, Double-blind Study of Safety and Prevention of Structural Joint Damage During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Rheumatoid Arthritis'

description: This 3 arm study will compare the safety and efficacy, with respect to a reduction in signs and symptoms and prevention of joint damage, of tocilizumab versus placebo, both in combination with methotrexate (MTX) in patients with moderate to severe active rheumatoid arthritis. Patients will be randomized to receive tocilizumab 4 mg/kg IV, tocilizumab 8 mg/kg IV or placebo IV, every 4 weeks. All patients will also receive methotrexate, 10-25 mg/week. The anticipated time on study treatment is 1-2 years and the target sample size is 500+ individuals. After completion of the 2 year study participants could participate in the optional 3 year open label extension phase (year 3 to 5).
DOI: 10.48370/ofd/tykoqk/j6y5bm
title: Erysiphe heraclei de Candolle F-0485.tif

description: :unav
DOI: 10.48370/ofd/tykoqk
title: Erysiphe heraclei de Candolle, 485

description: Fungarium Mikromycetes
DOI: 10.48370/ofd/fzerqf/7yvfmt
title: Erysiphe heraclei de Candolle F-2627.tif

description: :unav
DOI: 10.48370/ofd/fzerqf
title: Erysiphe heraclei de Candolle, 2627

description: Fungarium Mikromycetes
DOI: 10.48370/ofd/rkbynk/ejreee
title: Erysiphe heraclei de Candolle F-2622.tif

description: :unav
DOI: 10.48370/ofd/rkbynk
title: Erysiphe heraclei de Candolle, 2622

description: Fungarium Mikromycetes
DOI: 10.48370/ofd/fnucuf/tqoehr
title: Erysiphe heraclei de Candolle F-2599.tif

description: :unav
DOI: 10.48370/ofd/fnucuf
title: Erysiphe heraclei de Candolle, 2599

description: Fungarium Mikromycetes
DOI: 10.25934/pr00005671.1
title: Available IPD datapackage for study 'A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Active Rheumatoid Arthritis and Inadequate Response to Anti-TNF Therapy'

description: This 3 arm study will compare the safety and efficacy, with regard to reduction of signs and symptoms, of tocilizumab versus placebo in combination with methotrexate (MTX) in patients with moderate to severe active rheumatoid arthritis (RA) currently on MTX therapy, and who have had an inadequate response to prior therapy with an anti-tumor necrosis factor (anti-TNF) agent. Patients will be randomized to receive tocilizumab 4mg/kg iv, tocilizumab 8mg/kg or placebo iv, every 4 weeks. All patients will also receive methotrexate 10-25mg/week. The anticipated time on study treatment is 3-12 months, and the target sample size is 500+ individuals.
DOI: 10.48370/ofd/zapece/6m3d5c
title: Erysiphe heraclei de Candolle F-2587.tif

description: :unav
DOI: 10.48370/ofd/zapece
title: Erysiphe heraclei de Candolle, 2587

description: Fungarium Mikromycetes
DOI: 10.5281/zenodo.5938052
title: Dataset: Cross-Sectional National Survey on Risk Perception and Tourism Behaviour (SNF NRP 78)

description: The data set contains scales (<em>rating items</em>) on the willingness of the Swiss resident population to take risks in connection with touristic travel during the coronavirus pandemic. The data includes a selection of items of the <em>Domain-Specific Risk-Taking Scale</em> (<em>DOSPERT) </em>(Weber et al., 2002). The data contains measures of the <em>health belief model</em> (<em>HBM</em>; Rosenstock, 1960, see also Champion & Skinner, 2008) that is used both in health research and in tourism research to explain and predict the preventive health behaviour of individuals. Furthermore, the data covers all three elements of the t<em>heory of planned behaviour (</em>Ajzen, 1991). This is a representative data set for the Swiss population aged 18 and above. The address data was provided by the Federal Statistical Office (BfS). A trilingual and national survey of the Swiss resident population was carried out in the period from March to May 2021. A letter of invitation to participate in the study was sent by post to a total of 4,530 randomly selected persons residing in Switzerland. The address data was provided by the Federal Statistical Office (BfS). Of the total of 4,530 people contacted, 164 were reported as unreachable (no longer at the address, deceased, or due to old age). A total of 1,683 persons participated in the survey. This corresponds to a response rate of 39%. The structure of the respondents corresponds to that of the Swiss resident population 18 years of age and older with regard to gender, age, and language region. Ajzen, I. (1991). The theory of planned behavior. <em>Organizational Behavior and Human Decision Processes</em>, <em>50</em>(2), 179–211. https://doi.org/10.1016/0749-5978(91)90020-T Weber, E., Blais, A.-R., & Betz, N. E. (2002). A domain-specific risk-attitude scale: Measuring risk perceptions and risk behaviors. <em>Journal of Behavioral Decision Making</em>, <em>15</em>, 263–290. https://doi.org/10.1002/bdm.414 Champion, V. L., & Skinner, C. S. (2008). The health belief model. In K. Glanz, B. Rimer, & K. Viswanath (Eds.), <em>Health behavior and health education: Theory, research, and practice</em> (4th ed., pp. 45–65). San Francisco, CA: Jossey-Bass. Rosenstock, I. M. (1960). What research in motivation suggests for public health. <em>American Journal of Public Health, 50</em>(3), 295-302. https://doi.org/10.2105/AJPH.50.3_Pt_1.295
description: Supported by the Swiss National Science Foundation (SNSF) within the framework of the National Research Programme "Covid-19" (NRP 78) Grant-N° 4078P0_198336
DOI: 10.48370/ofd/pfcchh/0nbbjc
title: Erysiphe heraclei de Candolle F-2511.tif

description: :unav
DOI: 10.48370/ofd/pfcchh
title: Erysiphe heraclei de Candolle, 2511

description: Fungarium Mikromycetes
DOI: 10.25934/pr00005660.1
title: Available IPD datapackage for study 'Randomized, Multifactorial, Double-blind, Parallel-group, Dose-ranging Study of the Efficacy and Safety of Rituximab (MabThera®/Rituxan®) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis'

description: This study will assess the efficacy and safety of different treatment regimens of rituximab (MabThera®/Rituxan®), corticosteroids, and placebo, combined with methotrexate (MTX), in patients with active rheumatoid arthritis (RA).
DOI: 10.48370/ofd/x4vxfo/agg0p8
title: Erysiphe heraclei de Candolle F-0730.tif

description: :unav
DOI: 10.48370/ofd/x4vxfo
title: Erysiphe heraclei de Candolle, 730

description: Fungarium Mikromycetes
DOI: 10.3886/e145161
title: Data and Code for: Time Use and Gender in Africa in Times of Structural Transformation

description: These files contain data and code to replicate figures and tables in "Time Use and Gender in Africa in Times of Structural Transformation", by Taryn Dinkelman and L. Rachel Ngai. <br><br>Abstract: Many African countries are still in the early stages of structural transformation. Typically, as economies move through the structural transformation, activities once conducted within the household are outsourced to the market. This has particular implications for women’s time use. In this paper, we document that current patterns of female time use in home production in several African countries closely resemble historical time use patterns in the US. We highlight two stylized facts about women’s time use in Africa. First, in North Africa, women spend very few hours in market work and female labor force participation overall is extremely low. Second, although extensive margin participation of women is high in sub-Saharan Africa, women tend to work in the market for only a few hours each week, with the rest of their work hours spent in home production. These two facts suggest two different types of constraints that could slow down the reallocation of female time from home to market as economies grow: Social norms related to women’s market work, and a lack of infrastructure (e.g. household infrastructure and childcare facilities) to facilitate marketizing home production. We discuss recent empirical evidence related to each set of constraints and highlight new avenues for research.
DOI: 10.3886/e145161v2
title: Data and Code for: Time Use and Gender in Africa in Times of Structural Transformation

description: These files contain data and code to replicate figures and tables in "Time Use and Gender in Africa in Times of Structural Transformation", by Taryn Dinkelman and L. Rachel Ngai. <br><br>Abstract: Many African countries are still in the early stages of structural transformation. Typically, as economies move through the structural transformation, activities once conducted within the household are outsourced to the market. This has particular implications for women’s time use. In this paper, we document that current patterns of female time use in home production in several African countries closely resemble historical time use patterns in the US. We highlight two stylized facts about women’s time use in Africa. First, in North Africa, women spend very few hours in market work and female labor force participation overall is extremely low. Second, although extensive margin participation of women is high in sub-Saharan Africa, women tend to work in the market for only a few hours each week, with the rest of their work hours spent in home production. These two facts suggest two different types of constraints that could slow down the reallocation of female time from home to market as economies grow: Social norms related to women’s market work, and a lack of infrastructure (e.g. household infrastructure and childcare facilities) to facilitate marketizing home production. We discuss recent empirical evidence related to each set of constraints and highlight new avenues for research.
DOI: 10.48370/ofd/ifz9ja/lc3j9t
title: Erysiphe heraclei de Candolle F-2568.tif

description: :unav
DOI: 10.48370/ofd/ifz9ja
title: Erysiphe heraclei de Candolle, 2568

description: Fungarium Mikromycetes
DOI: 10.3886/e157681
title: Data and Code for: Political Distortions, State Capture, and Economic Development in Africa

description: These files contain the data for the journal article "Political Distortions, State Capture, and Economic Development in Africa" by Nathan Canen and Leonard Wantchekon.<br><br>The article studies the role of political distortions in driving economic outcomes in sub-Saharan Africa. We discuss how existing theories for development based on historical factors (e.g., pre-colonial and colonial institutions, or ethnic diversity) may not explain some new data from the region. We then consider a new framework based on political distortions, which includes state capture, the role of political connections, among others, in driving the variation in economic outcomes in the region, and use it to consider policies that may improve economic growth.
description: Country level data on economic and institutional outcomes (GDP, Corruption Perception Index, Polity Scores).
DOI: 10.3886/e157681v1
title: Data and Code for: Political Distortions, State Capture, and Economic Development in Africa

description: These files contain the data for the journal article "Political Distortions, State Capture, and Economic Development in Africa" by Nathan Canen and Leonard Wantchekon.<br><br>The article studies the role of political distortions in driving economic outcomes in sub-Saharan Africa. We discuss how existing theories for development based on historical factors (e.g., pre-colonial and colonial institutions, or ethnic diversity) may not explain some new data from the region. We then consider a new framework based on political distortions, which includes state capture, the role of political connections, among others, in driving the variation in economic outcomes in the region, and use it to consider policies that may improve economic growth.
description: Country level data on economic and institutional outcomes (GDP, Corruption Perception Index, Polity Scores).